Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bispecific antibodies
Biotech
AbbVie busts a move with Disco in $2.5B bispecific dance
The deal, which comes with $50 million upfront, grants AbbVie use of Disco’s mapping platform for finding cancer targets on a cell’s surface.
Michael Gibney
Nov 19, 2026 4:30am
Fierce Pharma
FDA slams China-heavy data in Summit’s ivonescimab CRL
Nov 17, 2026 4:48pm
Fierce Pharma
FDA rejects Summit’s PD-1xVEGF ivonescimab in NSCLC
Nov 15, 2026 7:50am
Fierce Pharma
BioNTech pays $205M for FDA voucher to speed up cancer pipeline
Nov 11, 2026 8:20am
T-Therapeutics raises $133M series B with Big Pharma backers
Nov 5, 2026 4:00am
Fierce Pharma
For Merck, 2027 is ‘another year of investment’
Oct 29, 2026 11:23am